Indus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.00 Cr
as on 16-11-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.78 Cr
as on 16-11-2024
- Satisfied Charges ₹ 26.96 Cr
as on 16-11-2024
- Revenue -37.00%
(FY 2023)
- Profit -15.68%
(FY 2023)
- Ebitda -4.15%
(FY 2023)
- Net Worth 21.68%
(FY 2023)
- Total Assets -8.90%
(FY 2023)
About Indus Life Sciences
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹26.78 Cr. The company has closed loans amounting to ₹26.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ganapathy Jayaram, Ramachandran Baskar, Ravichandran Venkatraman, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231TN2006PTC059530
- Company No.
059530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Indus Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnamurthymani  | Managing Director | 18-Apr-2006 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravichandran Venkatraman | Director | 18-Apr-2006 | Current |
| Ganapathy Jayaram | Director | 18-Apr-2006 | Current |
| Ramachandran Baskar | Director | 18-Apr-2006 | Current |
Financial Performance of Indus Life Sciences.
Indus Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37% decrease. The company also saw a substantial fall in profitability, with a 15.68% decrease in profit. The company's net worth Soared by an impressive increase of 21.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indus Life Sciences?
In 2023, Indus Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2020 | ₹26.78 Cr | Open |
Standard Chartered Bank Creation Date: 25 Nov 2016 | ₹6.60 M | Satisfied |
State Bank Of India Creation Date: 20 Dec 2014 | ₹26.30 Cr | Satisfied |
How Many Employees Work at Indus Life Sciences?
Indus Life Sciences has a workforce of 39 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
